| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $374K | -38.4% |
| Cost of Revenue | $258K | -75.6% |
| Gross Profit | $116K | +125.7% |
| R&D Expense | $505K | -81.2% |
| SG&A Expense | $5.7M | +14.3% |
| Operating Income | -$6.1M | +24.9% |
| Pre-tax Income | -$5.8M | +27.0% |
| Income Tax | $0 | — |
| Net Income | -$5.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.5M | -15.2% |
| Short-term Investments | $2.6M | — |
| Accounts Receivable | $79K | +139.4% |
| Current Assets | $9.7M | +21.3% |
| Total Assets | $10.9M | +16.7% |
| Current Liabilities | $1.1M | +56.9% |
| Total Liabilities | $1.4M | +27.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.0M | +25.6% |
| Capital Expenditures | $10K | -86.3% |
| Investing Cash Flow | -$2.7M | -1161.0% |
| Financing Cash Flow | $6.5M | +14.8% |
| Free Cash Flow | -$5.0M | +26.2% |
| +27.0% |
| EPS (Basic) | -$0.16 | +36.0% |
| EPS (Diluted) | -$0.16 | +36.0% |
| Stockholders' Equity |
| $9.6M |
| +15.3% |